Accent Capital Management »

GlaxoSmithKline shares owned by Accent Capital Management

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $34k 920 37.06

More positions owned by Accent Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf (SPY)
Alphabet Inc Class A Cl A Com (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Inc Class A Cl A Com (META)
Amazon (AMZN)
Visa (V)
Costco Wholesale Corporation (COST)
Alphabet Inc Class C Cl C Com (GOOG)
UnitedHealth (UNH)
Fiera Capital Corp
Mastercard Inc Class A Cl A Com (MA)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)

View all positions for Accent Capital Management

Top funds holding GlaxoSmithKline

Columbia Asset Management
Paradigm Asset Management Company
Accent Capital Management
Park Circle
Byrne Asset Management
Retirement Group
Huntington National Bank

View all funds holding GlaxoSmithKline